These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29931564)

  • 1. Antibodies to Influenza Virus Hemagglutinin in the 2016/2017 Epidemic Season in Poland.
    Hallmann-Szelińska E; Cieślak K; Kowalczyk D; Szymański K; Brydak LB
    Adv Exp Med Biol; 2018; 1108():69-74. PubMed ID: 29931564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of Influenza Hemagglutinin Antibodies in the Polish Population during the Epidemic Season 2017/18.
    Hallmann-Szelińska E; Szymański K; Łuniewska K; Masny A; Kowalczyk D; Sałamatin R; Brydak LB
    Adv Exp Med Biol; 2019; 1222():69-73. PubMed ID: 31637606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulation of Influenza Virus in the 2015/2016 Epidemic Season in Poland: Serological Evaluation of Anti-hemagglutinin Antibodies.
    Kowalczyk D; Szymański K; Cieślak K; Hallmann-Szelińska E; Brydak LB
    Adv Exp Med Biol; 2019; 1150():77-82. PubMed ID: 30276725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulation of Antibodies Against Influenza Virus Hemagglutinins in the 2014/2015 Epidemic Season in Poland.
    Kowalczyk D; Szymański K; Cieślak K; Brydak LB
    Adv Exp Med Biol; 2017; 968():35-40. PubMed ID: 28181197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland.
    Kondratiuk K; Hallmann E; Szymański K; Łuniewska K; Poznańska A; Brydak LB
    Acta Biochim Pol; 2024; 71():12289. PubMed ID: 38721309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in the Epidemic Season 2013/2014 in Poland.
    Bednarska K; Nowak MA; Kondratiuk K; Hallmann-Szelińska E; Brydak LB
    Adv Exp Med Biol; 2015; 857():45-50. PubMed ID: 25904002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemagglutinin Antibodies in the Polish Population during the 2019/2020 Epidemic Season.
    Szymański K; Kondratiuk K; Hallmann E; Poznańska A; Brydak LB
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutination inhibition antibody titers as a correlate of protection against influenza disease in the 2018/2019 epidemic season in Poland.
    Hallmann-Szelińska E; Szymański K; Łuniewska K; Kondratiuk K; Brydak LB
    Acta Biochim Pol; 2020 Mar; 67(1):93-98. PubMed ID: 32182410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of haemagglutinin influenza antibodies in the Polish population in the epidemic season 2020/2021 during the SARS-CoV-2 pandemic.
    Niedzielak M; Hallmann E; Kondratiuk K; Szymański K; Kolondra A; Poznańska A; Brydak L
    Acta Biochim Pol; 2022 Apr; 69(2):459-464. PubMed ID: 35485001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of population immunity of residents of Russian Federation regions against seasonal and highly pathogenic strains of influenza virus].
    Il'icheva TN; Durymanov AG; Petrova OV; Epanchintseva AV; Chukhrov IuS; Garbuz IuA; Bezgodov IV; Bulutov KV; Arkhipov GS; Samarskiĭ SS; Ziatdinov VB; Anan'ev VIu; Mikheev VN; Ryzhikov AB
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):120-3. PubMed ID: 25816528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Influenza in the Epidemic Season 2016/2017 Based on I-MOVE+ Project.
    Hallmann-Szelińska E; Cieślak K; Szymański K; Kowalczyk D; Korczyńska MR; Paradowska-Stankiewicz I; Brydak LB
    Adv Exp Med Biol; 2018; 1114():77-82. PubMed ID: 30203342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
    J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.